Literature DB >> 33956211

Hemorrhagic cerebral proliferative angiopathy in two pediatric patients: case reports.

Adalberto Ochoa1, Beatriz Mantese2, Flavio Requejo3.   

Abstract

Cerebral proliferative angiopathy (CPA) is an infrequent vascular malformation. It is composed of a nidus, arterial feeders, and venous drainage. Some special features differentiate it from the common arteriovenous malformations (AVM). The nidus has normal cerebral tissue intermingled and occupies a large portion of the brain. There is a frequent transdural arterial supply. Arterial feeders and draining veins are of small caliber concerning the nidus size. Ischemic strokes are the most common clinical event. Intracranial bleeding when occurs has a worse prognosis due to its high recurrence rate. We have presented two cases of CPA in pediatric patients who required surgical resolution of their acute episode.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Arteriovenous; Cerebral proliferative angiopathy; Decompressive craniectomy; Hemorrhagic stroke; Malformations

Mesh:

Year:  2021        PMID: 33956211     DOI: 10.1007/s00381-021-05181-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  11 in total

1.  Severely impaired cerebrovascular reserve in patients with cerebral proliferative angiopathy.

Authors:  Jorn Fierstra; Stephanie Spieth; Leanne Tran; John Conklin; Michael Tymianski; Karel G ter Brugge; Joseph A Fisher; David J Mikulis; Timo Krings
Journal:  J Neurosurg Pediatr       Date:  2011-09       Impact factor: 2.375

2.  Cerebral revascularization in cerebral proliferative angiopathy: a systematic review.

Authors:  Mohamed Somji; James McEachern; Joseph Silvaggio
Journal:  Neurosurg Focus       Date:  2019-02-01       Impact factor: 4.047

Review 3.  Progressive Cerebral Ischemia and Intracerebral Hemorrhage after Indirect Revascularization for a Patient with Cerebral Proliferative Angiopathy.

Authors:  Tomomi Kimiwada; Toshiaki Hayashi; Misaki Takahashi; Reizo Shirane; Teiji Tominaga
Journal:  J Stroke Cerebrovasc Dis       Date:  2019-02-06       Impact factor: 2.136

Review 4.  Cerebral proliferative angiopathy with tumor-like hemorrhage: A case report and literature review.

Authors:  Fatmir Bilaj; Arben Rroji; Eugen Enesi; Maren Ruka; Mentor Petrela
Journal:  Neuroradiol J       Date:  2016-06-20

5.  Large vascular malformation in a child presenting with vascular steal phenomenon managed with pial synangiosis.

Authors:  Michael J Ellis; Derek Armstrong; Peter B Dirks
Journal:  J Neurosurg Pediatr       Date:  2011-01       Impact factor: 2.375

6.  Development of Abnormal Hemispheric Vascular Networks Mimicking Cerebral Proliferative Angiopathy in a Child Originally Diagnosed with Deep-Seated Arteriovenous Fistula.

Authors:  Hiroyuki Sakata; Miki Fujimura; Kenichi Sato; Kuniyasu Niizuma; Hidenori Endo; Teiji Tominaga
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-08-20       Impact factor: 2.136

7.  MR perfusion imaging in proliferative angiopathy.

Authors:  D Ducreux; J F Meder; D Fredy; J Bittoun; P Lasjaunias
Journal:  Neuroradiology       Date:  2004-01-16       Impact factor: 2.804

8.  Cerebral proliferative angiopathy: clinical and angiographic description of an entity different from cerebral AVMs.

Authors:  Pierre L Lasjaunias; Pierre Landrieu; Georges Rodesch; Hortensia Alvarez; Augustin Ozanne; Staffan Holmin; Wen-Yuan Zhao; Sasikhan Geibprasert; Dennis Ducreux; Timo Krings
Journal:  Stroke       Date:  2008-01-31       Impact factor: 7.914

9.  Fatal hemorrhage in cerebral proliferative angiopathy.

Authors:  H Maekawa; M Tanaka; H Hadeishi
Journal:  Interv Neuroradiol       Date:  2012-09-10       Impact factor: 1.610

10.  Recurrent periventricular hemorrhage in cerebral proliferative angiopathy: Case report.

Authors:  Hidetsugu Maekawa; Aiko Terada; Tomoya Ishiguro; Masaki Komiyama; Stephanie Lenck; Leornardo Renieri; Timo Krings
Journal:  Interv Neuroradiol       Date:  2018-07-10       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.